JournalsHub
.online
Find My Journal
MM

Marcus Maurer

Walgreens (United States) US

ORCID iD 0000-0002-4121-481X
1,465
Publications
65,289
Citations
128
H-Index
746
i10-Index
8.8
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

Elevated baseline soluble FcεRI may be linked to early response to omalizumab treatment in chronic spontaneous urticaria OA

S. Moñino-Romero, P. Kolkhir, T. Ohanyan, Z. Szépfalusi, K. Weller - Journal of the European Academy of Dermatology and Venereology, 2023
Cited by 5 Semantic Scholar

Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria. OA

D. Skander, A. Allenova, M. Maurer, P. Kolkhir - European Annals of Allergy and Clinical Immunology, 2020
Cited by 7 Semantic Scholar

Interleukin‐17 is a potential player and treatment target in severe chronic spontaneous urticaria

D. Sabag, L. Matanes, Jacob Bejar, H. Sheffer, A. Barzilai - Clinical and Experimental Allergy, 2020
Cited by 74 Semantic Scholar

ALLERGIC DERMATOSIS AND URTICARIA ( J RING , SECTION EDITOR ) Physical Urticaria

M. Abajian, M. Agnieszka, ynek, M. Maurer - Unknown Venue, 2012
Cited by 0 Semantic Scholar

Research Topics

Urticaria and Related Conditions (819) Coagulation, Bradykinin, Polyphosphates, and Angioedema (460) Mast cells and histamine (418) Autoimmune Bullous Skin Diseases (392) Dermatology and Skin Diseases (302)

Affiliations

University of Notre Dame
US 1981 - 1981
Goethe University Frankfurt
DE 2024 - 1995
Novartis (Switzerland)
CH 2004 - 2004
Oxfam
GB 2021 - 2019
World Health Organization - Pakistan
PK 2012 - 2012

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now